Determination of KRAS- and ERK-regulated phosphoproteomes in KRAS-mutant cancers

被引：0
|
作者：
Klomp, Jennifer E. [1 ]
Klomp, Jeff A. [1 ]
Diehl, Nathaniel J. [1 ]
Edwards, Cole A. [1 ]
Drizyte-Miller, Kristina [1 ]
Hibshman, Priya S. [1 ]
Yang, Runying [1 ]
Morales, Alexis J. [1 ]
Taylor, Khalilah E. [1 ]
Pierobon, Mariaelena [2 ]
Petricoin, Emanuel F., III [2 ]
Jared, Johnson L. [3 ]
Huntsman, Emily M. [3 ]
Yaron, Tomer M. [4 ]
Vaha-Koskela, Markus [5 ]
Herring, Laura E. [1 ]
Prevatte, Alex W. [1 ]
Barker, Natalie K. [1 ]
Graves, Lee M. [1 ]
Krister, Wennerberg [5 ]
Cantley, Lewis C. [3 ]
Christensen, James G. [6 ]
Cox, Adrienne D. [1 ]
Der, Channing J. [1 ]
Stalnecker, Clint A. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] George Mason Univ, Fairfax, VA USA
[3] Weill Cornell Med, New York, NY USA
[4] Columbia Univ, Vagelos Coll Physicians & Surg, New York, NY USA
[5] Univ Copenhagen, Copenhagen, Denmark
[6] Mirati Therapeut, San Diego, CA USA
来源：
MOLECULAR CANCER RESEARCH | 2023年 / 21卷 / 05期
关键词：
D O I：
10.1158/1557-3125.RAS23-B034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B034
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
    Cox, Adrienne D.
    Goodwin, Craig M.
    Bryant, Kirsten L.
    Dagliyan, Irem
    George, Samuel D.
    Lucas, Kelly E.
    Gautam, Prson
    Wennerberg, Krister
    Der, Channing J.
    CANCER RESEARCH, 2018, 78 (13)
  • [32] Current therapy of KRAS-mutant lung cancer
    Ghimessy, Aron
    Radeczky, Peter
    Laszlo, Viktoria
    Hegedus, Balazs
    Renyi-Vamos, Ferenc
    Fillinger, Janos
    Klepetko, Walter
    Lang, Christian
    Dome, Balazs
    Megyesfalvi, Zsolt
    CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1159 - 1177
  • [33] A step towards treating KRAS-mutant NSCLC
    Goldberg, Sarah B.
    Schlessinger, Joseph
    Boyer, Julie L.
    Herbst, Roy S.
    LANCET ONCOLOGY, 2013, 14 (01): : 3 - 5
  • [34] Role of silent mutations in KRAS-mutant tumors
    Lu, Jun
    Zhou, Chao
    Pan, Feng
    Liu, Hongyu
    Jiang, Haohua
    Zhong, Hua
    Han, Baohui
    CHINESE MEDICAL JOURNAL, 2025, 138 (03) : 278 - 288
  • [35] Genetic modifiers of KRAS-mutant colorectal cancer
    Tjader, Nijole P.
    Ramroop, Johnny
    Gandhi, Tanish
    Campbell, Peter T.
    Chan, Andrew T.
    Gallinger, Steven
    Giles, Graham G.
    Gunter, Marc J.
    Harrison, Tabitha A.
    Hoffmeister, Michael
    Newcomb, Polly A.
    Ogino, Shuji
    Phipps, Amanda I.
    Qu, Conghui
    Schoen, Robert E.
    Pellatt, Andrew
    Woods, Michael O.
    Van Guelpen, Bethany
    Stevens, Patrick
    Hampel, Heather
    Peters, Ulrike
    McElroy, Joseph P.
    Toland, Amanda E.
    CANCER RESEARCH, 2024, 84 (06)
  • [36] ERK-dependent protein phosphorylation in KRAS-mutant cancer: a mix of the expected and surprising
    Huang, Kevin
    Wang, Yubao
    Roberts, Thomas M.
    TRENDS IN BIOCHEMICAL SCIENCES, 2025, 50 (01) : 6 - 8
  • [37] Current therapy of KRAS-mutant lung cancer
    Aron Ghimessy
    Peter Radeczky
    Viktoria Laszlo
    Balazs Hegedus
    Ferenc Renyi-Vamos
    Janos Fillinger
    Walter Klepetko
    Christian Lang
    Balazs Dome
    Zsolt Megyesfalvi
    Cancer and Metastasis Reviews, 2020, 39 : 1159 - 1177
  • [38] Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
    Hatzivassiliou, Georgia
    Haling, Jacob R.
    Chen, Huifen
    Song, Kyung
    Price, Steve
    Heald, Robert
    Hewitt, Joanne F. M.
    Zak, Mark
    Peck, Ariana
    Orr, Christine
    Merchant, Mark
    Hoeflich, Klaus P.
    Chan, Jocelyn
    Luoh, Shiuh-Ming
    Anderson, Daniel J.
    Ludlam, Mary J. C.
    Wiesmann, Christian
    Ultsch, Mark
    Friedman, Lori S.
    Malek, Shiva
    Belvin, Marcia
    NATURE, 2013, 501 (7466) : 232 - 236
  • [39] Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
    Georgia Hatzivassiliou
    Jacob R. Haling
    Huifen Chen
    Kyung Song
    Steve Price
    Robert Heald
    Joanne F. M. Hewitt
    Mark Zak
    Ariana Peck
    Christine Orr
    Mark Merchant
    Klaus P. Hoeflich
    Jocelyn Chan
    Shiuh-Ming Luoh
    Daniel J. Anderson
    Mary J. C. Ludlam
    Christian Wiesmann
    Mark Ultsch
    Lori S. Friedman
    Shiva Malek
    Marcia Belvin
    Nature, 2013, 501 : 232 - 236
  • [40] Temporal inhibition of ERK is sufficient for tumor growth inhibition in KRAS-mutant or BRAF-mutant tumors
    Bhagwat, Shripad V.
    Shen, Weihua
    Zhao, Baohui
    Cai, Shufen
    Kindler, Lisa
    McMillen, William T.
    Yuen, Eunice
    McCann, Denis
    Manro, Jason
    Dropsey, Andrew J.
    Willard, Melinda D.
    Joseph, Sajan
    Peng, Sheng-Bin
    CANCER RESEARCH, 2020, 80 (16)
12345